Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof inventions 04/07

20070093645 - Peptide vectors: The invention features targeted cytotoxic compounds and methods relating to their therapeutic use for the treatment of neoplasia and other conditions.... Agent: Brian R Morrill Biomeasure, Incorporated

20070093646 - Crystalline vap-1 and uses thereof: The present invention relates to crystalline vascular adhesion protein-1 (VAP-1) and in particular to methods for the use of structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design and production, as well as screening assays for detection of same. The invention further relates to inhibitors identified by... Agent: Birch Stewart Kolasch & Birch

20070093647 - Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Hamilton, Brook, Smith & Reynolds, P.C.

20070093648 - Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Hamilton, Brook, Smith & Reynolds, P.C.

20070093649 - Process for purifying interferon beta: Provided is a process for purifying human interferon beta from a recombinant human interferon beta-containing culture comprising performing affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC), wherein the affinity chromatography includes: adsorbing the interferon beta-containing culture to an equilibrated affinity chromatography column, followed by washing with an equilibration buffer solution;... Agent: Rothwell, Figg, Ernst & Manbeck, P.C.

20070093650 - Nucleic acid and proteins showing increased expression dose under salt stress: A nucleic acid and a protein increasing expression levels under salt stress provide a nucleic acid with a nucleic acid sequence of SEQ. ID. NO. 1 in Sequence Listing, a variant nucleic acid thereof, a protein with an amino acid sequence of SEQ. ID. NO. 2 in Sequence Listing, and... Agent: Oblon, Spivak, Mcclelland, Maier & Neustadt, P.C.

20070093651 - Ligand: The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity.... Agent: Palmer & Dodge, LLP Kathleen M. Williams

20070093652 - Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings: The present invention describes novel dyes, including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings. The dyes of the invention absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings. Many of the dyes of the invention are useful fluorescent dyes.... Agent: Invitrogen Corporation C/o Intellevate

20070088150 - Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Hamilton, Brook, Smith & Reynolds, P.C.

20070088151 - Secreted and transmembrane polypeptides and nucleic acids encoding the same: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides... Agent: Heller Ehrman LLP

20070083036 - Decreasing allergenicity of natural latex rubber prior to vulcanization: A method for reducing allergenicity of natural latex rubber. The natural latex rubber, prior to its vulcanization, is admixed with silica compounds dissolved an alkali solution to denature the antigenic protein thus reducing the total protein level. Alternatively, liquid sodium silicate is added directly to natural rubber latex to reduce... Agent: Dergosits & Noah LLP

20070083037 - Monkey npy y4 receptor and method of evaluating compound: It is intended to provide a nucleic acid represented by SEQ ID NO: 1 or 3; a protein represented by SEQ ID NO: 2 or 4; a recombinant vector containing a gene which comprises the above-described nucleic acid; a nonhuman primate NPY Y4 gene obtained by using a transformed cell... Agent: Merck And Co., Inc

20070083038 - Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Hamilton, Brook, Smith & Reynolds, P.C.

20070083039 - Method of separating and recovering acid/sugar solution and lignophenol derivative from lignocellulosic material: It is an object to provide a method in which a lignocellulosic material is treated with a phenol derivative and acid, whereby a lignophenol derivative can be recovered, and moreover sugar from an acid/sugar solution obtained at the same time can be recovered and used easily and efficiently. One form... Agent: Browdy And Neimark, P.l.l.c. 624 Ninth Street, Nw

20070078258 - Purification process: This invention a process for purifying a cyclosporin, e.g. cyclosporin A, or a macrolide, to a high degree of purity on a large scale. In another aspect this invention provides a bulk quantity of cyclosporin A with an impurity level of less than about 0.7%, e.g. about 0.5%, and composition... Agent: Novartis Corporate Intellectual Property

20070078259 - Uses of human zven proteins and polynucleotides: The present invention provides methods of using Zven1 and Zven2 polypeptides to increase chemokine production. The present invention also provides methods for treating intestinal motility disorders and improving gastrointestinal function with Zven1 and Zven2 polypeptides.... Agent: Zymogenetics, Inc. Intellectual Property Department

20070078260 - Chemokine panec-2 polynucleotides, polypeptides, antibodies and methods of making and using them: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2,... Agent: Foley And Lardner LLP Suite 500